NSAIDs: Old Drugs Reveal New Anticancer Targets

By Piazza Gary A.   Keeton Adam B.   Tinsley Heather N.   Whitt Jason D.   Gary Bernard D.   Mathew Bini   Singh Raj   Grizzle William E.   Reynolds Robert C.  

Pharmaceuticals, Vol. 3, Iss. 5, 2010-05 ,pp. : 1652-1667

MDPI

Access to resources Recommend Favorite

Insights into the Binding Sites of Organometallic Ruthenium Anticancer Compounds on Peptides Using Ultra-High Resolution Mass Spectrometry

By Wills Rebecca   Habtemariam Abraha   Lopez-Clavijo Andrea   Barrow Mark   Sadler Peter   O’Connor Peter  

Journal of The American Society for Mass Spectrometry, Vol. 25, Iss. 4, 2014-04 ,pp. : 662-672

Springer Publishing Company

Access to resources Recommend Favorite

Ruthenium oxide for effective activation of aluminium sacrificial anodes: a new approach

By Shibli S. M. A.   George S.   Gireesh V. S.  

British Corrosion Journal, Vol. 37, Iss. 2, 2002-07 ,pp. : 126-128

Maney Publishing

Access to resources Recommend Favorite

The Synthesis of Some New Sulfur Heterocyclic Compounds as Potential Radioprotective and Anticancer Agents

By Ghorab M.   Osman A.   Noaman E.   Heiba H.   Zaher N.  

Phosphorus, Sulfur, and Silicon and the Related Elements, Vol. 181, Iss. 8, 2006-08 ,pp. : 1935-1950

Taylor & Francis Ltd

Access to resources Recommend Favorite

A QSAR, Pharmacokinetic and Toxicological Study of New Artemisinin Compounds with Anticancer Activity

By Vieira Josinete B.   Braga Francinaldo S.   Lobato Cleison C.   Santos César F.   Costa Josivan S.   Bittencourt José Adolfo H. M.   Brasil Davi S. B.   Silva Jocivânia O.   Hage-Melim Lorane I. S.   Macêdo Williams Jorge C.   Carvalho José Carlos T.   Santos Cleydson Breno R.  

Molecules, Vol. 19, Iss. 8, 2014-07 ,pp. : 10670-10697

MDPI

Access to resources Recommend Favorite